This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

September 15-18, 2025

Hynes Convention CenterBoston, USA

Development of Emerging Cell & Gene Therapies Stream: From AI applications and multiplex gene editing to optimized delivery systems and next-generation manufacturing processes.

Hear from industry experts revolutionizing CGT bioprocessing through stromal-free production methods, strategic CDMO partnerships, and cutting-edge case studies that are reshaping the future of advanced therapeutics.

View the Development of Emerging Cell & Gene Therapies Agenda Download the Full Agenda

Development of Emerging Cell & Gene Therapies Speakers

Click on the speaker's profile to view their sessions on the agenda:

Jeron Chen

Head of Data Science and Payload Innovation

Voyager Therapeutics

Reagan Jarvis

Chief Executive Officer and Co-founder

Anocca

Kate Rochlin

Chief Operating Officer

IN8bio

Francesca Vitelli, PhD

Former VP Cell Therapy and Viral Vector PD and MSAT

Intellia Therapeutics, Inc

See More Speakers Here!

Development and Emerging Cell and Gene Therapy Topics

Harnessing AI and Machine Learning for the Future of Cell & Gene Therapy Development

Session Details

Efficient and Liver-Detargeted In Vivo Multiplex Gene Editing of Human Hematopoietic Stem and Progenitor Cells

Session Details

Optimizing LNP Delivery and Non-Viral Vector Manufacturing as Scalable, Redosable Alternatives to Viral Vectors

Session Details

Cell and Gene Therapy CDMO Selection and External Manufacturing Best Practices

Session Details

Stromal-Free, GMP-Compatible Bioprocess for Generating Allogeneic CAR-γδ T Cells from Cord Blood CD34+ HSPC

Session Details

Development of Next-Gen Cell and Gene Therapies Case Studies

Session Details

Download the 2025 BPI Agenda